Andrew W. Michell

2.6k total citations · 2 hit papers
24 papers, 1.7k citations indexed

About

Andrew W. Michell is a scholar working on Neurology, Cellular and Molecular Neuroscience and Molecular Biology. According to data from OpenAlex, Andrew W. Michell has authored 24 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Neurology, 8 papers in Cellular and Molecular Neuroscience and 4 papers in Molecular Biology. Recurrent topics in Andrew W. Michell's work include Neurological disorders and treatments (7 papers), Parkinson's Disease Mechanisms and Treatments (7 papers) and Genetic Neurodegenerative Diseases (6 papers). Andrew W. Michell is often cited by papers focused on Neurological disorders and treatments (7 papers), Parkinson's Disease Mechanisms and Treatments (7 papers) and Genetic Neurodegenerative Diseases (6 papers). Andrew W. Michell collaborates with scholars based in United Kingdom, United States and Australia. Andrew W. Michell's co-authors include Roger A. Barker, Angela Vincent, Bethan Lang, Alessandro S. Zagami, Michael R. Johnson, Ernest Somerville, Sarosh R. Irani, Andrew Bleasel, Patrick Waters and Jonathan M. Schott and has published in prestigious journals such as Brain, Annals of Neurology and The Lancet Neurology.

In The Last Decade

Andrew W. Michell

23 papers receiving 1.6k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Faciobrachial dystonic seizures precede Lgi1 antibody limbic encephalitis

2010 600 citations Sarosh R. Irani, Andrew W. Michell et al. Annals of Neurology profile →
Autologous mesenchymal stem cells for the treatment of secondary progressive multiple sclerosis: an open-label phase 2a proof-of-concept study

2012 457 citations Peter Connick, Madhan Kolappan et al. The Lancet Neurology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Andrew W. Michell United Kingdom	13	896	470	313	294	170	24	1.7k
Keyi Yang United States	24	561 0.6×	761 1.6×	130 0.4×	422 1.4×	95 0.6×	45	1.6k
Carola Krüger Germany	16	270 0.3×	518 1.1×	233 0.7×	324 1.1×	117 0.7×	21	1.5k
Glenn Lopate United States	21	787 0.9×	326 0.7×	218 0.7×	466 1.6×	126 0.7×	35	1.4k
Gen Sobue Japan	21	514 0.6×	447 1.0×	229 0.7×	623 2.1×	147 0.9×	53	1.3k
Tomohisa Furuta Japan	20	397 0.4×	524 1.1×	240 0.8×	314 1.1×	54 0.3×	65	1.3k
Chen Zhang China	16	753 0.8×	529 1.1×	112 0.4×	490 1.7×	133 0.8×	91	1.5k
Sabrina W. Yum United States	25	297 0.3×	880 1.9×	225 0.7×	543 1.8×	174 1.0×	63	1.8k
Leslie Bridges United Kingdom	27	834 0.9×	887 1.9×	246 0.8×	222 0.8×	132 0.8×	78	2.4k
Aleksanteri Aspelund Finland	6	616 0.7×	448 1.0×	162 0.5×	1.0k 3.5×	95 0.6×	7	2.5k
Maya H. Nisancioglu Sweden	6	299 0.3×	890 1.9×	176 0.6×	280 1.0×	226 1.3×	7	2.4k

Countries citing papers authored by Andrew W. Michell

Since Specialization

Citations

This map shows the geographic impact of Andrew W. Michell's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Andrew W. Michell with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Andrew W. Michell more than expected).

Fields of papers citing papers by Andrew W. Michell

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Andrew W. Michell. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Andrew W. Michell. The network helps show where Andrew W. Michell may publish in the future.

Co-authorship network of co-authors of Andrew W. Michell

This figure shows the co-authorship network connecting the top 25 collaborators of Andrew W. Michell. A scholar is included among the top collaborators of Andrew W. Michell based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Andrew W. Michell. Andrew W. Michell is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Fachner, Jörg, Clemens Maidhof, D. J. Murtagh, et al.. (2023). Music therapy, neural processing, and craving reduction: an RCT protocol for a mixed methods feasibility study in a Community Substance Misuse Treatment Service. Addiction Science & Clinical Practice. 18(1). 36–36. 2 indexed citations

Needham, Edward, Virginia Newcombe, Andrew W. Michell, et al.. (2020). Mononeuritis multiplex: an unexpectedly frequent feature of severe COVID-19. Journal of Neurology. 268(8). 2685–2689. 50 indexed citations

Michell, Andrew W., et al.. (2018). Feasibility Trial of Treatment of Ulnar Neuropathy at the Elbow Using a Specifically Designed Splint. JCR Journal of Clinical Rheumatology. 26(1). 37–39. 2 indexed citations

Thornton, John S., et al.. (2016). Advances in EEG: home video telemetry, high frequency oscillations and electrical source imaging. Journal of Neurology. 263(10). 2139–2144. 4 indexed citations

Brown, J William L, Peter J. Martin, John Thorpe, et al.. (2014). Long-term remission with rituximab in refractory leucine-rich glioma inactivated 1 antibody encephalitis. Journal of Neuroimmunology. 271(1-2). 66–68. 26 indexed citations

Singh, Harsimrat, Robert J. Cooper, Andrea Edwards, et al.. (2014). Mapping cortical haemodynamics during neonatal seizures using diffuse optical tomography: A case study. NeuroImage Clinical. 5. 256–265. 44 indexed citations

Connick, Peter, Madhan Kolappan, Charles Crawley, et al.. (2012). Autologous mesenchymal stem cells for the treatment of secondary progressive multiple sclerosis: an open-label phase 2a proof-of-concept study. The Lancet Neurology. 11(2). 150–156. 457 indexed citations breakdown →

Thornton, John S. & Andrew W. Michell. (2012). Techniques and applications of EMG: measuring motor units from structure to function. Journal of Neurology. 259(3). 585–594. 10 indexed citations

Breen, David P., Andrew W. Michell, & Roger A. Barker. (2011). Parkinson's disease – the continuing search for biomarkers. Clinical Chemistry and Laboratory Medicine (CCLM). 49(3). 393–401. 15 indexed citations

10.

Vaccarino, Anthony L., Terrence Sills, Karen E. Anderson, et al.. (2011). Assessment of Motor Symptoms and Functional Impact in Prodromal and Early Huntington Disease. PLoS Currents. 2. RRN1244–RRN1244. 6 indexed citations

11.

Irani, Sarosh R., Andrew W. Michell, Bethan Lang, et al.. (2010). Faciobrachial dystonic seizures precede Lgi1 antibody limbic encephalitis. Annals of Neurology. 69(5). 892–900. 600 indexed citations breakdown →

12.

O’Keeffe, Gráinne C., Andrew W. Michell, & Roger A. Barker. (2009). Biomarkers in Huntington's and Parkinson's Disease. Annals of the New York Academy of Sciences. 1180(1). 97–110. 22 indexed citations

13.

Barker, Roger A. & Andrew W. Michell. (2009). “The eyes have it”. Saccadometry and Parkinson's disease. Experimental Neurology. 219(2). 382–384. 3 indexed citations

14.

Lazic, Stanley E., Sarah Mason, Andrew W. Michell, & Roger A. Barker. (2009). Visualising disease progression on multiple variables with vector plots and path plots. BMC Medical Research Methodology. 9(1). 32–32. 6 indexed citations

15.

Phillips, Wendy, et al.. (2009). Animal Models of Neurodegenerative Diseases. Methods in molecular biology. 549. 137–155. 12 indexed citations

16.

Michell, Andrew W., David E. Mosedale, David J. Grainger, & Roger A. Barker. (2008). Metabolomic analysis of urine and serum in Parkinson’s disease. Metabolomics. 4(3). 191–201. 75 indexed citations

17.

Phillips, Wendy, Andrew W. Michell, & Roger A. Barker. (2006). Neurogenesis in Diseases of the Central Nervous System. Stem Cells and Development. 15(3). 359–379. 12 indexed citations

18.

Underwood, Benjamin R., David Broadhurst, Warwick B. Dunn, et al.. (2006). Huntington disease patients and transgenic mice have similar pro-catabolic serum metabolite profiles. Brain. 129(4). 877–886. 156 indexed citations

19.

Harrower, Timothy, Andrew W. Michell, & Roger A. Barker. (2005). Lewy bodies in Parkinson's disease: Protectors or perpetrators?. Experimental Neurology. 195(1). 1–6. 21 indexed citations

20.

Michell, Andrew W., Leila M. Luheshi, & Roger A. Barker. (2005). Skin and platelet α-synuclein as peripheral biomarkers of Parkinson's disease. Neuroscience Letters. 381(3). 294–298. 80 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact